Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Letrozole may help prevent seizures by reducing certain hormone levels.

Letrozole reduces seizures but not brain damage in mice.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Aromatase inhibitors cause male pattern hair loss in women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

The inhibitor affects androgen metabolism but not ovarian function.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Using steroids can increase the risk of heart problems.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Testosterone helps human pancreatic cells increase insulin release.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.